BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15944106)

  • 1. Use of complementary and alternative medicine in patients with cancer: a UK survey.
    Scott JA; Kearney N; Hummerston S; Molassiotis A
    Eur J Oncol Nurs; 2005 Jun; 9(2):131-7. PubMed ID: 15944106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary and alternative medicine among cancer patients in Israel.
    Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
    Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.
    Algier LA; Hanoglu Z; Ozden G; Kara F
    Eur J Oncol Nurs; 2005 Jun; 9(2):138-46. PubMed ID: 15899593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
    Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
    Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine use in patients with head and neck cancers in Europe.
    Molassiotis A; Ozden G; Platin N; Scott JA; Pud D; Fernandez-Ortega P; Milovics L; Panteli V; Gudmundsdottir G; Browall M; Madsen E; Patiraki E; Kearney N
    Eur J Cancer Care (Engl); 2006 Mar; 15(1):19-24. PubMed ID: 16441673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of New Zealand adults about complementary and alternative therapies for cancer treatment.
    Trevena J; Reeder A
    N Z Med J; 2005 Dec; 118(1227):U1787. PubMed ID: 16372036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of complementary and alternative therapies by cancer patients in northern Israel.
    Hana G; Bar-Sela G; Zhana D; Mashiach T; Robinson E
    Isr Med Assoc J; 2005 Apr; 7(4):243-7. PubMed ID: 15847205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and expenditure on complementary medicine in England: a population based survey.
    Thomas KJ; Nicholl JP; Coleman P
    Complement Ther Med; 2001 Mar; 9(1):2-11. PubMed ID: 11264963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine use in patients with haematological malignancies in Europe.
    Molassiotis A; Margulies A; Fernandez-Ortega P; Pud D; Panteli V; Bruyns I; Scott JA; Gudmundsdottir G; Browall M; Madsen E; Ozden G; Magri M; Selvekerova S; Platin N; Kearney N; Patiraki E
    Complement Ther Clin Pract; 2005 May; 11(2):105-10. PubMed ID: 15955292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine: oncology nurses' experiences, educational interests, and resources.
    Rojas-Cooley MT; Grant M
    Oncol Nurs Forum; 2006 May; 33(3):581-8. PubMed ID: 16676014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine (CAM) among hospitalised patients: an Australian study.
    Shorofi SA; Arbon P
    Complement Ther Clin Pract; 2010 May; 16(2):86-91. PubMed ID: 20347839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complementary therapies by Australian women with breast cancer.
    Kremser T; Evans A; Moore A; Luxford K; Begbie S; Bensoussan A; Marigliani R; Zorbas H
    Breast; 2008 Aug; 17(4):387-94. PubMed ID: 18534852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of traditional medicine and globalized complementary and alternative medicine among low-income cancer service users in Brazil.
    Tovey P; de Barros NF; Hoehne EL; Carvalheira JB
    Integr Cancer Ther; 2006 Sep; 5(3):232-5. PubMed ID: 16880428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
    Rakovitch E; Pignol JP; Chartier C; Ezer M; Verma S; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2005 Mar; 90(2):139-48. PubMed ID: 15803360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
    Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.